• DAEHWA Pharm CEO Kim Eun Seok bought 1,200 common shares on Nov. 6, 2026, at 9,018 won per share.
• His holdings rose to 233,300 shares from 232,100; the disclosed stake remained at 1.25%.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. DAEHWA Pharm. Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261113000096), on November 13, 2026, and is solely responsible for the information contained therein.